Aimei Health Technology Co., Ltd
Aimei Health Technology Co., Ltd
Your view on AFJK
Overview
What the company does, where it operates, and who runs it.
About Aimei Health Technology Co., Ltd
- Industry
- Shell Companies
- Sector
- Financial Services
- CEO
- Junheng Xie
- Headquarters
- US
- Industry
- Shell Companies
- Sector
- Financial Services
- CEO
- Junheng Xie
- Headquarters
- US
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.
It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Aimei Health Technology Co., Ltd, and the rating behind it. AFJK last traded at $12.30, 179.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Aimei Health Technology Co., Ltd. Starting points for Aimei Health Technology Co., Ltd: P/E 179.6, EPS $0.40, beta 0.55 — an Shell Companies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Aimei Health Technology Co., Ltd. Aimei Health Technology Co., Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Aimei Health Technology Co., Ltd. Trailing twelve-month EPS for Aimei Health Technology Co., Ltd stands at $0.40. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Aimei Health Technology Co., Ltd. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Aimei Health Technology Co., Ltd valued side by side against its closest peers. Aimei Health Technology Co., Ltd is measured against Shell Companies peers within the Financial Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Aimei Health Technology Co., Ltd, and how their positions are changing. At a $38.9M market value, institutional positions materially move Aimei Health Technology Co., Ltd's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Aimei Health Technology Co., Ltd executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Aimei Health Technology Co., Ltd. Aimei Health Technology Co., Ltd is a $38.9M Financial Services company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Aimei Health Technology Co., Ltd. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Aimei Health Technology Co., Ltd. Coverage tracks Aimei Health Technology Co., Ltd within Shell Companies (Financial Services). Press releases and market coverage, newest first.